Potassium channels in atrial fibrillation: targets for atrial and pathology-specific therapy?
Ravens
Ursula
U
Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany. ravens@rcs.urz.tu-dresden.de
D000200:Action Potentials / Q000502:physiology; D000818:Animals; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006801:Humans; D026902:Potassium Channel Blockers / Q000494:pharmacology*; D015221:Potassium Channels / Q000187:drug effects* / Q000502:physiology
D026902:Potassium Channel Blockers; D015221:Potassium Channels